Navigation Links
Specialty Blades, Inc. Expands Management Team With New VP Engineering
Date:9/14/2007

STAUNTON, Va., Sept. 14 /PRNewswire-USNewswire/ -- Michael Bond has been named the VP Engineering for IncisionTech/Specialty Blades. Bond joins the company following nearly 30 years in various roles for Gillette, including most recently as the Assistant Director of Blade Process Engineering. Bond has a wealth of experience in engineering management that will enable continued advancement of leading edge technologies for IncisionTech and Specialty Blades.

"The global markets we serve are expanding in both size and complexity, leading our business through a period of transformational growth. We are excited about the opportunity to have Mike as a key member of our management team," said Peter Harris, Specialty Blades' President and CEO. "Mike will lead our efforts to expand our Center of Excellence for incisional products and compete on a global basis by deploying innovative and advanced manufacturing technologies."

About Specialty Blades

Specialty Blades helps flexible packaging and other industrial companies improve their cutting, sealing and separating processes by providing the very best knives and blades for their application. No other potential partner has our unique set of skills or technologies that produces parts that improve the cutting process by improving blade wear, reducing scrap, and decreasing machine downtime. More information can be found on Specialty Blades at http://www.specialtyblades.com.

About IncisionTech

IncisionTech provides critical cutting and piercing components and sub- assemblies used in surgical devices. Its unique position in the surgical market comes from a 100% focus on cutting and piercing device functionality. This makes IncisionTech the strategic partner of choice for medical device OEMs seeking to improve patient outcomes through better device performance. For more information about IncisionTech visit

SOURCE Specialty Blades, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. All Specialty Care Treatments Will Be Offered At Belle Vue.
2. Inhospitable Response Curtail Growth Of Specialty Hospitals: United States
3. Apollo to Open Super-specialty Hospital in Oman by Year-end
4. Envisaged Specialty Training Programme For Junior Doctors Encounters a Speed Breaker
5. Reliance Group to Develop Specialty Blood Products
6. Vasan Group to Open Eight Specialty Eye Hospitals
7. Early Prostate Cancer: Specialty of Physician Influences Type of Therapy Received
8. The Cleveland Clinic Expands Its Services across the World via the Net
9. Ranbaxy Expands By Acquiring A Generic Company In Belgium
10. Insulin and Growth Hormone, Expands Life Span?
11. Health Insurance Company Expands Product Range
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... (PRWEB) July 11, 2014 According to ... & Application Market by Communication Technology (ZigBee, Z-Wave, Bluetooth, ... Electronics, Industrial, Automotive & Transportation, Agriculture) & Geography - ... value of Internet of Things market was worth $1029.5 ... Billion by 2020, at an estimated CAGR of 4.08% ...
(Date:7/11/2014)... Presently, disposable medical suppliers call for the ... segment. During the past two decades, the world market ... average 12.5% per year), primarily owing to the importance ... is the largest market for disposable medical supplies in ... second position is held by Europe with a 29% ...
(Date:7/11/2014)... 10, 2014) Obese and overweight firefighters are ... care providers, according to new research from The ... (UTHealth). , National guidelines state that health care ... of maintaining a healthy weight. Firefighters have high ... leading cause of line-of-duty deaths in firefighters. This ...
(Date:7/11/2014)... to repair damage to the anterior cruciate ligament (ACL) -- ... could increase a young athlete,s risk for further injuries, researchers ... aged 8 to 16, who had ACL reconstruction surgery. Of ... their injury, 37 had surgery six to 12 weeks after, ... their injury. The youngsters who had surgery later had ...
(Date:7/11/2014)... Ticket Down is a reliable source for cheap ... CA. Over the years Luke Bryan has been honored by ... he do well at award shows, but each summer, he hits ... tours of the genre and this summer is more of the ... to the popularity and success that is currently entitled to Luke ...
Breaking Medicine News(10 mins):Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 2Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 3Health News:Delaying Kid's Knee Surgery Could Be a Bad Play, Study Finds 2Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 2Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 3
... June 5 The combination of two different chemotherapies ... cancers is not effective against advanced melanoma, according to ... 46th annual meeting of the American Society of Clinical ... we learn something important about the treatment of melanoma," ...
... ... that a less-invasive technique called sentinel node resection is just as safe ... the underarm area, according to a new study being presented today at ... National Surgical Adjuvant Breast and Bowel Project (NSABP) and Allegheny General Hospital ...
... chemotherapy, new drug prolonged lives of some with advanced ... report they prolonged survival for some patients with advanced ... is currently only about six months. , One ... tumors in the majority of lung cancer patients with ...
... drugs approved for treatment of drug-resistant chronic myeloid leukemia ... therapy than the existing front-line medication, according to two ... of Medicine . Separate international phase III ... treatment between the standard-of-care drug imatinib, also known as ...
... CHICAGO - Dasatanib, a medication currently approved as treatment ... quicker, better responses as a first therapy than the ... of Texas MD Anderson Cancer Center. The findings ... American Society of Clinical Oncology today, and published in ...
... early because of supplement,s poor performance , SATURDAY, June ... selenium doesn,t reduce the likelihood of lung cancer recurrence, ... D. Karp, a professor in the department of thoracic/head ... M.D. Anderson Cancer Center, is scheduled to present the ...
Cached Medicine News:Health News:Combination treatment regimen not effective against advanced melanoma 2Health News:Less-invasive Lymph Node Resection Following Breast Cancer Surgery Confirmed as Standard of Care in Eight-year Study Led by AGH Doctors 2Health News:Researchers Report Treatment Headway Against Lung Cancer 2Health News:Researchers Report Treatment Headway Against Lung Cancer 3Health News:Second-line CML drugs evoke faster, better front-line remissions 2Health News:Second-line CML drugs evoke faster, better front-line remissions 3Health News:Second-line CML drug evokes faster response, fewer side effects, pivotal study finds 2Health News:Don't Count on Selenium to Prevent Lung Cancer Recurrence 2
(Date:1/15/2014)... N.Y. , Jan. 15, 2014 Sono-Tek Corporation (OTC ... months ended November 30, 2013, compared to sales of $2,202,000 ... 20%. Once again, this quarter has also shown growth over ... the first quarter of this fiscal year. Markets that experienced ...
(Date:1/15/2014)... , Jan. 15, 2014 Most osteoporosis patients ... to a recent online survey* sponsored by Mission Pharmacal ... the National Osteoporosis Foundation online support community, revealed that ... medication that comes in a form other than a ...
(Date:1/15/2014)... RAPIDS, Mich. , Jan. 15, 2014 As health ... the flu virus, select Meijer pharmacies in Michigan ... strep throat to eligible patients, enabling Meijer pharmacists to administer ... strict protocol set by a physician participating in the study. ...
Breaking Medicine Technology:Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... 20 Radius Health ("Radius") announced today that it ... institutional financing round, increasing total Series C investment to ... company,s inception to $106.5 million. All existing institutional investors ... NVS Strategic Fund and including MPM Capital, The Wellcome ...
... Amgen,(Nasdaq: AMGN ) and Millennium: ... Company Limited (TSE: 4052), today announced that,enrollment in ... 706) in,combination with paclitaxel and carboplatin for the ... has been temporarily suspended,following a planned safety data ...
Cached Medicine Technology:Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7
... HYDROLYSER Percutaneous Thrombectomy Catheter is ... for rapid, effective and easy removal ... shunts. The HYDROLYSER catheter provides an ... thrombolytic therapy. ,Compatible with ...
Introduced more than 30 years ago by Dr. Thomas J. Fogarty, these embolectomy catheters are indicated for the removal of fresh, soft emboli and thrombi from vessels in the arterial system....
... The AVX catheter is designed ... to 12mm. High-pressure saline jets travel ... sound to create a low pressure ... is drawn into the catheter where ...
Redel Connector 10 Pin...
Medicine Products: